How can quantum computing be applied in clinical trial design and optimization?

Hakan Doga,Aritra Bose,M Emre Sahin,Joao Bettencourt-Silva,Anh Pham,Eunyoung Kim,Alan Andress,Sudhir Saxena,Laxmi Parida,Jan Lukas Robertus,Hideaki Kawaguchi,Radwa Soliman,Daniel Blankenberg,M. Emre Sahin
DOI: https://doi.org/10.1016/j.tips.2024.08.005
IF: 17.638
2024-10-04
Trends in Pharmacological Sciences
Abstract:Clinical trials are necessary for assessing the safety and efficacy of treatments. However, trial timelines are severely delayed with minimal success due to a multitude of factors, including imperfect trial site selection, cohort recruitment challenges, lack of efficacy, absence of reliable biomarkers, etc. Each of these factors possesses a unique computational challenge, such as data management, trial simulations, statistical analyses, and trial optimization. Recent advancements in quantum computing offer a promising opportunity to overcome these hurdles. In this opinion we uniquely explore the application of quantum optimization and quantum machine learning (QML) to the design and execution of clinical trials. We examine the current capabilities and limitations of quantum computing and outline its potential to streamline clinical trials.
pharmacology & pharmacy
What problem does this paper attempt to address?